Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Routine Breast Cancer Screening Makes Mark In U.K. Panel Review

This article was originally published in The Gray Sheet

Executive Summary

Based on an analysis of 11 randomized trials, a government-commissioned panel in the U.K. calculated a 20% relative risk reduction in breast cancer death among women who were invited for routine mammography screening.


Related Content

Federal Task Force Plans New Look Into Breast Cancer Screening
Studies Point To Shortcomings, Some Opportunities In Breast Cancer Screening



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts